Researchers are exploring the potential of dna methylation biomarkers in liquid biopsies, with a focus on creating a roadmap for clinical application. The use of cell-free dna is also being investigated for its relevance in certain diseases, such as lupus. Additionally, work is being done on induced pluripotency in stem cell development, although it is unclear how directly this relates to the development of dna methylation biomarkers.